Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine for prophylaxis of postoperative delirium in high‑risk surgical patients
2016-004117-27Phase 3Terminated
- Sponsor
- Hospital Universitario de Salamanca
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative delirium (POD) comparing Quetiapine prophylaxis with Placebo (2 arms). Primary endpoint: Incidence of postoperative delirium within 4 days. Started Dec 2017; status: terminated.
02
Drugs
quetiapine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on 2016-004117-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004117-27.